Activating mutations in the FSH receptor (FSHR) gene have been shown to confer a higher response to FSH and therefore FSHR genotype may predispose women to OHSS [20], Although FSHR genotype cannot predict the risk of iatrogenic OHSS at present, it may be used to predict the severity of the condition. This evidence concerns the gene BRD2 and ovarian hyperstimulation syndrome.